About ABT Molecular Imaging
ABT Molecular Imaging is a Healthcare company based in Louisville (United States) founded in 2006 by Lynda Nutt and Ronald Nutt. It operates as a biomarker generators for PET molecular imaging are manufactured. ABT Molecular Imaging has raised $29.07 million across 11 funding rounds from investors including SWK Holdings, River Cities Capital and Mountain Group Partners. Its focus areas include Life Sciences, Imaging Diagnostics, Accessories and Radioisotopes. Its competitors include ImaginAb, AC Immune, APRINOIA, BioArctic and Blue Earth Diagnostics and 2 more; 5 of its 7 listed competitors have raised funding.
Company details
ABT Molecular Imaging was founded in 2006 in Louisville, United States, and operates in the medical imaging sector. Generators such as the BG-75 model are produced to create unit doses of positron emission tomography (PET) biomarkers at the point of use. Quality control tests are conducted for each dose, and records are maintained for every generation. Operations focus on supporting molecular imaging applications in healthcare settings.
- Headquarters Louisville, United States
- Founders Lynda Nutt, Ronald Nutt
- SectorsHealthcare
- Phone•••• ••••
- Website bestabt.com
- Total Equity Funding$29.07M (USD)
in 11 rounds
- Latest Funding Round$10M (USD), Series C
Oct 2014
- InvestorsSWK Holdings
& 4 more
Funding Insights of ABT Molecular Imaging
ABT Molecular Imaging has successfully raised a total of $29.07M across 11 strategic funding rounds. The most recent funding activity was a Series C round of $10 million completed in October 2014. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $29.07M
- Total Rounds 11
- Last Round Series C — $10M
- First Round $9M
(Oct 2009)
- Investors Count 5
Latest 10 of 11 funding rounds of ABT Molecular Imaging with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct 2014 | $10M | Series C | – | SWK Holdings | – |
| Aug 2014 | $750,000 | Debt – Conventional | – | – | – |
| May 2014 | $775,000 | Debt – Conventional | – | – | – |
| Apr 2014 | $800,000 | Debt – Conventional | – | – | – |
| Feb 2014 | $500,000 | Debt – Conventional | – | – | – |
| Dec 2013 | $401,010 | Debt – Conventional | – | – | – |
| Sep 2012 | $6.05M | Series C | – | River Cities Capital | |
| Aug 2012 | $150,000 | Debt – Conventional | – | – | – |
| Mar 2012 | $500,000 | Debt – Conventional | – | – | – |
| Jun 2011 | $4.01M | Series A | – | – | – |
5 investors in total: 5 institutional.
Investors in ABT Molecular Imaging
ABT Molecular Imaging has secured backing from 5 investors, including institutional and venture fund investors. Prominent investors backing the company include SWK Holdings, River Cities Capital and Mountain Group Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
- | – | rccf.com | - | |
Venture capital is directed toward life sciences and technology sectors. | – | mtngp.com | Nashville, United States | |
Council Capital is focused on healthcare investment and support. | 2000 | councilcapital.com | Nashville, United States | |
Early-stage life sciences and tech focused VC firm funding companies in the US | – | intersouth.com | Durham, United States | |
Investments and advisory services are provided by the holding company. | 2009 | swkhold.com | Dallas, United States |
Investor details for ABT Molecular Imaging
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of ABT Molecular Imaging
2 people are tracked at ABT Molecular Imaging (2 in leadership).
| Name | Role | Group |
|---|---|---|
Lynda Nutt | Co-Founder | Leadership |
Ronald Nutt | Co-Founder | Leadership |
Complete people profiles for ABT Molecular Imaging
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of ABT Molecular Imaging
3 dated milestones of ABT Molecular Imaging across 8 years, from founding to its latest funding, stage changes and deals.
- Founded ABT Molecular Imaging is founded.
- Funding First funding round of $9.0M.
- Funding Latest funding round, Series C, of $10.0M.
Competitors of ABT Molecular Imaging
ABT Molecular Imaging has 7 listed competitors in our database, 5 of them funded. They include ImaginAb, AC Immune, APRINOIA, BioArctic and Blue Earth Diagnostics, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| imaginab.com | 2007 | Los Angeles, United States | $59.64M | 17 | ImaginAb is focused on developing advanced immuno-oncology imaging technologies. | |
| acimmune.com | 2003 | Lausanne, Switzerland | $119.82M | – | Antibodies, small molecules, and vaccines are developed for neurodegenerative diseases. | |
| aprinoia.com | 2015 | Taipei, Taiwan | $51.1M | 15 | Diagnostics and therapeutics for neurodegenerative disorders are developed. | |
| bioarctic.com | 2003 | Bromma, Sweden | – | – | Disease-modifying treatments for neurodegenerative diseases are developed. | |
| blueearthdiagnostics.com | 2014 | Oxford, United Kingdom | $49.42M | 38 | Radioactive molecular imaging agents for cancer are developed. | |
| nuviewlifesciences.com | 2005 | Park, United States | $90M | – | Cancer diagnosis devices targeting VPAC1 receptors are developed. | |
| cancertargetedtechnology.com | 2006 | Woodinville, United States | – | 4 | Cancer Targeted Technology is focused on developing small molecule drugs for cancer diagnosis and treatment. |
Detailed competitors of ABT Molecular Imaging
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of ABT Molecular Imaging
The website of ABT Molecular Imaging (bestabt.com) receives about 1K visits a month.
- Monthly visits1K
▼ 67.1% vs previous month
Top companies in Imaging Diagnostics
10 companies that operate in the same segment as ABT Molecular Imaging (Imaging Diagnostics), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Handheld ultrasound devices are developed for whole-body medical imaging. | 2011 | Guilford, Connecticut, United States | USD 350 M | USD 97.61 M | 464 | |
Technology tools and systems for molecular scale are developed. | 1959 | Abingdon, Oxfordshire, United Kingdom | – | USD 648.1 M | – | |
MR-interfaced ultrasound devices for cancer and neurology treatments are provided. | 1999 | Tirat Carmel, Haifa District, Israel | USD 574.2 M | – | 541 | |
Robotic microsurgical systems for endoscopy are developed. | 2007 | Redwood City, California, United States | USD 733.62 M | – | 91 | |
Manufacturer of imaging and surgical products | 1919 | Tokyo, Tokyo, Japan | – | USD 6.49 B | 35,933 | |
Ultrasound images are analyzed via AI-based software provided by Exo. | 2015 | Redwood City, California, United States | USD 463.39 M | – | – | |
Planar X-ray radiology products for diagnostic imaging are supplied. | 2000 | Oxford, Oxfordshire, United Kingdom | USD 43.43 M | USD 1.04 M | 50 | |
Digital X-ray sources are developed by Nanox for cloud-based diagnostics. | 2004 | Jerusalem, Jerusalem District, Israel | USD 110.72 M | USD 13.02 M | 165 | |
ImaginAb is focused on developing advanced immuno-oncology imaging technologies. | 2007 | Los Angeles, California, United States | USD 59.64 M | – | – | |
Portable wireless ultrasound systems are developed for medical imaging. | 2014 | Burnaby, British Columbia, Canada | USD 21.87 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Abt Molecular Imaging
Complete news archive for ABT Molecular Imaging
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about ABT Molecular Imaging
ABT Molecular Imaging was founded in 2006 and raised its 1st funding round 3 years after it was founded.
ABT Molecular Imaging is headquartered in Louisville, United States. It is registered at Louisville, Kentucky, United States.
ABT Molecular Imaging is a funded company, having raised a total of $29.07M across 11 funding rounds to date. The company's 1st funding round was a Series A of $4.01M, raised on Oct 2009.
ABT Molecular Imaging was founded in 2006 in Louisville, United States, and operates in the medical imaging sector. Generators such as the BG-75 model are produced to create unit doses of positron emission tomography (PET) biomarkers at the point of use. Quality control tests are conducted for each dose, and records are maintained for every generation. Operations focus on supporting molecular imaging applications in healthcare settings.
ABT Molecular Imaging has 5 investors. Key investors include SWK Holdings, River Cities Capital, Mountain Group Partners, Council Capital, and Intersouth Partners.